Abstract submission deadline: 7 April 2017
Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system. The deadline for submissions is 7 April 2017.
- Human vaccines - infectious diseases
- Human vaccines - non-infectious diseases
- Veterinary vaccines
- Vaccine safety
- Clinical studies and field trials
- Vectors / adjuvants / drug delivery
- Production / manufacturing
- Regulatory / societal / economic / programmatic / legislation subjects
- Immunology / animal models
- Virus and VLP Bioprocessing
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.
Once the abstracts is accepted, at least one of the authors must register for and present at the conference.
All authors who register for the conference may have their article considered for publication in the Elsevier journal Vaccine, by indicating this at abstract submission stage. Acceptance of a paper for conference presentation does not guarantee subsequent acceptance for journal publication.
Abstracts of all accepted contributions will be included within the online abstract system which will be distributed to all registered conference participants.
For revisions or queries regarding papers already submitted
If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please contact the Conference Content Executive (Please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one.